Barry Wolf

Barry Wolf is a Principal Research Scientist at AbbVie Biotherapeutics, bringing over 10 years of experience in the biotechnology industry and academia focused on mammalian cell culture processes for protein production. They previously held positions at companies such as Biogen, Abbott Biotherapeutics, and PDL BioPharma, where they developed process technologies and managed pilot plant operations. Barry earned dual degrees in Mechanical Engineering and Biology from Rutgers University, followed by a Ph.D. and M.S. in Chemical Engineering from the University of Michigan. Their primary interest lies in leveraging cellular metabolism to enhance protein productivity and quality.